CA2835728A1 - Marqueurs moleculaires dans le cancer de la prostate - Google Patents

Marqueurs moleculaires dans le cancer de la prostate Download PDF

Info

Publication number
CA2835728A1
CA2835728A1 CA2835728A CA2835728A CA2835728A1 CA 2835728 A1 CA2835728 A1 CA 2835728A1 CA 2835728 A CA2835728 A CA 2835728A CA 2835728 A CA2835728 A CA 2835728A CA 2835728 A1 CA2835728 A1 CA 2835728A1
Authority
CA
Canada
Prior art keywords
prostate cancer
expression
prostate
hoxc4
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2835728A
Other languages
English (en)
Inventor
Franciscus Petrus Smit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOVIOGENDIX RESEARCH BV
Original Assignee
NOVIOGENDIX RESEARCH BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NOVIOGENDIX RESEARCH BV filed Critical NOVIOGENDIX RESEARCH BV
Publication of CA2835728A1 publication Critical patent/CA2835728A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA2835728A 2011-05-12 2012-05-08 Marqueurs moleculaires dans le cancer de la prostate Abandoned CA2835728A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EPPCT/EP2011/057714 2011-05-12
EP2011057714 2011-05-12
PCT/EP2012/058473 WO2012152800A1 (fr) 2011-05-12 2012-05-08 Marqueurs moléculaires dans le cancer de la prostate

Publications (1)

Publication Number Publication Date
CA2835728A1 true CA2835728A1 (fr) 2012-11-15

Family

ID=46052746

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2835728A Abandoned CA2835728A1 (fr) 2011-05-12 2012-05-08 Marqueurs moleculaires dans le cancer de la prostate

Country Status (3)

Country Link
AU (1) AU2012252426A1 (fr)
CA (1) CA2835728A1 (fr)
WO (1) WO2012152800A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120041274A1 (en) 2010-01-07 2012-02-16 Myriad Genetics, Incorporated Cancer biomarkers
US20120053253A1 (en) 2010-07-07 2012-03-01 Myriad Genetics, Incorporated Gene signatures for cancer prognosis
WO2012030840A2 (fr) 2010-08-30 2012-03-08 Myriad Genetics, Inc. Signatures génétiques pour le diagnostic et le pronostic du cancer
EP2920322B1 (fr) 2012-11-16 2023-01-11 Myriad Genetics, Inc. Signatures génétiques utilisées en vue du pronostic d'un cancer
CA2921098A1 (fr) * 2013-08-13 2015-02-19 Noviogendix Research B.V. Combinaisons de marqueurs moleculaires du cancer de la prostate, permettant d'obtenir un outil de diagnostic ayant une sensibilite/specificite ameliorees
AU2014373927B2 (en) * 2013-12-30 2018-03-22 Genomatix Prostate cancer gene profiles and methods of using the same
CA2947624A1 (fr) 2014-05-13 2015-11-19 Myriad Genetics, Inc. Signatures genetiques utilisees en vue du pronostic d'un cancer
US10329625B2 (en) 2015-11-20 2019-06-25 Mdxhealth Research B.V. Method for detecting DLX1 mRNA, HOXC6 mRNA, and KLK3 mRNA in a urine sample and predicting and treating clinically significant prostate cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0625321D0 (en) * 2006-12-19 2007-01-24 Univ Surrey Cancer biomarker
US20100047787A1 (en) * 2008-02-25 2010-02-25 Biotheranostics, Inc. Prostate cancer survival and recurrence

Also Published As

Publication number Publication date
AU2012252426A1 (en) 2013-11-28
WO2012152800A1 (fr) 2012-11-15

Similar Documents

Publication Publication Date Title
AU2009299862B2 (en) Molecular markers in prostate cancer
US20210246515A1 (en) COMBINATION OF mRNA EXPRESSION LEVELS OF DLX1 AND HOXC6 IN URINE AS MOLECULAR MARKERS IN PROSTATE CANCER
CA2835728A1 (fr) Marqueurs moleculaires dans le cancer de la prostate
Hessels et al. Applicability of biomarkers in the early diagnosis of prostate cancer
CA2853745C (fr) Combinaisons de marqueurs moleculaires dans le cancer de la prostate fournissant un outil de diagnostic ayant une sensibilite/specificite amelioree
JP5865241B2 (ja) 肉腫の予後分子署名およびその使用
US20140106363A1 (en) Molecular markers in prostate cancer
Schalken et al. Molecular prostate cancer pathology: current issues and achievements
EP2334809B1 (fr) Marqueurs moléculaires pour le cancer de la prostate
EP3348652B1 (fr) Marqueurs moléculaires du cancer de la prostate
EP2707500A1 (fr) Marqueurs moléculaires dans le cancer de la prostate
JP2021515587A (ja) 分子シグネチャー及び低悪性度前立腺癌の同定のためのその使用
CA2904126C (fr) Marqueurs moleculaires dans le cancer de la vessie
EP2773768B1 (fr) Combinaisons de marqueurs moléculaires dans le cancer de la prostate fournissant un outil de diagnostic ayant une sensibilité/spécificité améliorée
EP3696283B1 (fr) Marqueurs moléculaires dans le cancer de la vessie
Saramäki Gene copy number alterations in prostate cancer

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20180510